Astellas Pharma, Inc. (ALPMY)
16.19
-0.01
(-0.06%)
USD |
OTCM |
Feb 19, 16:00
Astellas Pharma EPS Diluted (Quarterly) : 0.3625 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.5548 |
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1226 |
| AnGes, Inc. | -0.0052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 651.15M |
| Revenue (Quarterly) | 3.707B |
| Total Expenses (Quarterly) | 3.056B |
| Enterprise Value | 32.02B |
| Gross Profit Margin (Quarterly) | 73.89% |
| Profit Margin (Quarterly) | 17.56% |
| Earnings Yield | 7.40% |
| Operating Earnings Yield | 9.30% |
| Normalized Earnings Yield | 7.405 |